1887

Abstract

Introduction:

Mucormycosis is usually an invasive mycotic disease caused by fungi in the class Mucormycetes. It often occurs in immunocompromised patients but sporadic cases without apparent immune impairment have been described.

Case presentation:

Here we report a case of rhinofacial mucormycosis due to in a 55‐year‐old diabetic female. She presented with diabetic ketoacidosis and nasal obstruction, nasal discharge and right‐sided cheek swelling following sinus surgery, which had been performed at a private hospital 1 month previously. Endoscopic biopsy was performed and the sample was sent for histopathological examination and KOH wet mount, which showed broad, pauci‐septate hyphae with right‐angle branching. The tissue was inoculated onto Sabouraud dextrose agar and white mycelial growth was obtained which turned grey with age. Morphological identification confirmed it as . antifungal susceptibility testing was performed by means of the microbroth dilution method according to CLSI Approved Standard M38‐A. The isolate was found to be susceptible to amphotericin B, itraconazole and posaconazole but resistant to voriconazole and echinocandins. Functional endoscopic sinus surgery was performed and local necrotic tissue was debrided. The patient was put on liposomal amphotericin B, with a successful outcome.

Conclusion:

Early diagnosis is critical in prevention of morbidity and mortality associated with disease.

Loading

Article metrics loading...

/content/journal/jmmcr/10.1099/jmmcr.0.002931
2014-09-01
2019-11-17
Loading full text...

Full text loading...

/deliver/fulltext/jmmcr/1/3/jmmcr002931.html?itemId=/content/journal/jmmcr/10.1099/jmmcr.0.002931&mimeType=html&fmt=ahah

References

  1. CLSI( 2005;). Reference Method for Broth Dilution Antifungal Susceptibility. Testing of Filamentous Fungi: Approved Standard M38‐A Wayne PA: Clinical and Laboratory Standards Institute;
    [Google Scholar]
  2. Cornely O.A., Arikan‐Akadaqli S., Dannaoui E., Groll A.H., Lagrou K., Chakrabrati A., Lanternier F., Pagano L., Skiada A.. other authors( 2014;). ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbial Infect20:Suppl. 35–26[CrossRef]
    [Google Scholar]
  3. De Hoog G.S., Guarro J., Gene J., Figueras M.J.. ( 2000;). Atlas of Clinical Fungi, 2nd edn. Utrecht: Centraalbureau voor Schimmelcutures;
  4. De Pauw B.. ( 2008;). Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis46:1813–1821[CrossRef]
    [Google Scholar]
  5. Dökmetaş H.S., Canbay E., Yilmaz S., Elaldi N., Topalkara A., Oztoprak I., Yildiz E.. ( 2002;). Diabetic ketoacidosis and rhino‐orbital mucormycosis. Diabetes Res Clin Pract57:139–142[CrossRef]
    [Google Scholar]
  6. Germain S., Robert A., Ishak M., Tremblay C., Claveau S.. ( 1993;). Infection due to Rhizomucor pusillus: report of four cases in patients with leukemia and review. Clin Infect Dis16:640–645[CrossRef]
    [Google Scholar]
  7. Gomes M.Z.R., Lewis R.E., Kontoyiannis D.P.. ( 2011;). Mucormycosis caused by unusual Mucormycetes, non‐Rhizopus, ‐Mucor and ‐Lichtheimia species. Clin Microbiol Rev24:411–445[CrossRef]
    [Google Scholar]
  8. Hernanz D.P., Garraus Fereres. J., Noriega S.L., A. R. Sanz S.F.. ( 1983;). Nosocomial infection by Rhizomucor pusillus in a clinical haematology unit. J Hosp Infect4:45–49[CrossRef]
    [Google Scholar]
  9. Iwen P.C., Freifeld A.G., Sigler L., Trantolo S.R.. ( 2005;). Molecular identification of Rhizomucor pusillus as a cause of sinus‐orbital zygomycosis in a patient with acute myelogenous leukemia. J Clin Microbiol43:5819–5821[CrossRef]
    [Google Scholar]
  10. Kimura M., Udawaga S., Makimura K., Satho K., Toyazaki N., Ito H.. ( 2009;). Isolation and identification of Rhizomucor pusillus from pleural zygomycosis in an immunocompetent patient. Med Mycol47:869–873[CrossRef]
    [Google Scholar]
  11. Lu X.L., Liu Z.H., Shen Y.N., She X.D., Lu G.X., Zhan P., Liu W.D.. ( 2009;). Primary cutaneous zygomycosis caused by Rhizomucor variabilis: a case report and review of 6 cases reported from China. Clin Infect Dis49:e39–e43[CrossRef]
    [Google Scholar]
  12. Ribes J.A., Vanover‐Sams C.L., Baker D.J.. ( 2002;). Zygomycetes in human disease. Clin Microbiol Rev13:236–301[CrossRef]
    [Google Scholar]
  13. Roden M.M., Zaoutis T.E., Buchanan W.L., Knudsen T.A., Sarkisova A., Schaufele R.L., Sein M., Chiou C.C., Chu J.H.. other authors( 2005;). Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis41:634[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmmcr/10.1099/jmmcr.0.002931
Loading
/content/journal/jmmcr/10.1099/jmmcr.0.002931
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error